This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jul;48(1):345-6.

doi: 10.1002/hep.22235.

Antiviral effects of silymarin against hepatitis C: the jury is still out

Stephen J Polyak, Chihiro Morishima, Roy Hawke

PMID: 18509876
DOI: 10.1002/hep.22235

Comment

Antiviral effects of silymarin against hepatitis C: the jury is still out

Stephen J Polyak et al. Hepatology. 2008 Jul.

. 2008 Jul;48(1):345-6.

doi: 10.1002/hep.22235.

Authors

Stephen J Polyak, Chihiro Morishima, Roy Hawke

PMID: 18509876
DOI: 10.1002/hep.22235

No abstract available

PubMed Disclaimer

Comment on

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group. Seeff LB, et al. Hepatology. 2008 Feb;47(2):605-12. doi: 10.1002/hep.22044. Hepatology. 2008. PMID: 18157835 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

R21 AT002895/AT/NCCIH NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley